Synthace
- Revenue£581FY, 2013
- Total Funding$41.8 M
OverviewSuggest Edit
The UK’s first dedicated synthetic biology company with a world leading platform of technologies for the rapid engineering and optimisation of novel biological production systems. A spin out of University College London, Synthace is already producing high-value research and development products for the pharmaceutical, agrochemical and fine chemicals industry. Synthace bioengineering is enabled by a tight integration of computational modelling and big data analysis with wet lab experimental design and validation, and novel molecular biology tools. While Synthace bioengineering is broadly applicable across multiple industry sectors, the company is focused towards applications in the production of specialty chemicals.
| Type | Private | |
| Founded | 2011 | |
| HQ | London, GB | Map |
| Website | synthace.com | |
| Employee Ratings |
Key People/Management at Synthace
Christopher Grant Ward
Co-founder, Head Of Research And Development
Fane Mensah
Life Sciences Business Director
Markus Gershater
Co-founder, Chief Scientific Officer
Mark Watson
Chief Commercial Officer
Synthace Office Locations
Synthace has offices in London and Cambridge
London, GB (HQ)
195 Wood Ln, Shepherd's Bush
Cambridge, MA, US
101 Main St
Synthace Financials and Metrics
Summary Metrics
Founding Date | 2011 |
Synthace total Funding | $41.8 m |
Synthace latest funding size | $25.6 m |
Time since last funding | 4 years ago |
Synthace investors | Horizons Ventures, Amadeus Capital Partners, Sofinnova Partners, Rainbow Seed Fund, David Lucas, John Anthony Knight, Keith Willey, Michail Eleftheriou, Sami Mikati, Sharaf Yamani, SOSV, White Cloud Capital, Eleven Two Capital, Bioeconomy Capital, Luminous Ventures, Patrick Zhang |
Synthace's latest funding round in December 2018 was reported to be $25.6 m. In total, Synthace has raised $41.8 m
Synthace Revenue
Synthace's revenue was reported to be £581 in FY, 2013
| GBP | |
|---|---|
Revenue (FY, 2013) | 581.0 |
Net income (FY, 2013) | (361.6k) |
EBITDA (FY, 2013) | (356.8k) |
EBIT (FY, 2013) | (361.6k) |
Cash (31-May-2018) | 4.9m |
| GBP | FY, 2012 | FY, 2013 |
|---|---|---|
Revenue | 581.0 | |
Operating expense total | 362.2k | |
EBITDA | (356.8k) | |
EBITDA margin, % | (61413%) |
| GBP | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|---|---|---|---|
Cash | 351.4k | 103.4k | 321.7k | 1.5m | 245.0k | 224.3k | 4.9m |
Accounts Receivable | 240.0 | 159.9k | 73.2k | 9.6k | 46.6k | 107.7k | |
Current Assets | 358.1k | 150.1k | 481.6k | 1.6m | 646.8k | 883.2k | 5.8m |
PP&E | 1.6k | 14.8k | 298.8k | 200.5k | 265.6k | 186.8k | 235.7k |
| GBP | FY, 2012 | FY, 2013 |
|---|---|---|
Net Income | (43.1k) | (361.6k) |
| GBP | FY, 2012 |
|---|---|
Financial Leverage | 1 x |
Synthace Cybersecurity Score
Synthace Online and Social Media Presence
1.72k Twitter followers
Synthace has 1.72k Twitter Followers. The number of followers has increased 0.4% month over month and increased 0.6% quarter over quarter
Synthace's Trends
Twitter Engagement Stats for @synthace
1.5k
Tweets
192
Following
1.7k
Followers
3
Tweets last 30 days
1.7
Avg. likes per Tweet
100%
Tweets with engagement
Synthace News and Updates
November 16, 2021
Synthace raises $35 million, helps scientists automate biology experimentation and insight sharing
London’s Synthace has raised $35 million in a Series C funding round. The life sciences company provides an R&D cloud platform that gives scientists around the globe the ability to […]
The post Synthace raises $35 million, helps scientists automate biology experimentation and insight sharing ap…
December 12, 2018
Synthace raises $25.6 million to automate bio labs with software
Synthace, a U.K. startup developing an operating system to automate lab work, announced that it has raised $25.6 million in a Series B round.
September 19, 2017
Synthace reels in $9.6 mln Series A
London-based Synthace, the developer of the Antha operating system for biology, has raised $9.6 million in Series A funding. The investors included White Cloud Capital, Amadeus Capital Partners, Eleven Two Capital, Sofinnova Partners, SOSV and Bioeconomy Capital.
Synthace Blogs
April 22, 2022
Earth Day 2022: We Need Biology in the Fight Against Climate Change. But Are We Ready To Use It?
Earth Day 2022: We Need Biology in the Fight Against Climate Change. But Are We Ready To Use It? Filter Search by keyword Browse by category Article Bioprocessing Gene Therapy Lab of the Future News Our People Uncategorised Tags AI Assay Development Automation Biology Bioprocessing Carbon Climate Ch…
April 11, 2022
How to Make High Throughput Design of Experiments the Norm in Assay Development
How to Make High Throughput Design of Experiments the Norm in Assay Development Filter Search by keyword Browse by category Article Bioprocessing Gene Therapy Lab of the Future News Our People Uncategorised Tags AI Assay Development Automation Bioprocessing concentration normalization Conference Cus…
April 05, 2022
UCL Selects Synthace to Help Make Digital, Cloud-Based Lab Work a Reality
UCL Selects Synthace to Help Make Digital, Cloud-Based Lab Work a Reality Filter Search by keyword Browse by category Article Bioprocessing Gene Therapy Lab of the Future News Our People Uncategorised Tags AI Automation Bioprocessing concentration normalization Conference Customer Success Data Demo …
April 04, 2022
How to Normalize Concentrations in a Fraction of the Time
How to Normalize Concentrations in a Fraction of the Time Filter Search by keyword Browse by category Article Bioprocessing Gene Therapy Lab of the Future News Our People Uncategorised Tags AI Automation Bioprocessing concentration normalization Conference Customer Success Data Demo Design of Experi…
March 28, 2022
Too Many Hats: How Biology Drains Biologists
Too Many Hats: How Biology Drains Biologists Filter Search by keyword Browse by category Article Bioprocessing Gene Therapy Lab of the Future News Our People Uncategorised Tags AI Automation Bioprocessing Conference Customer Success Data Demo Design of Experiments (DOE) DNA Assembly ELISA Engineerin…
March 15, 2022
How To Get Started With Design of Experiments
How To Get Started With Design of Experiments Filter Search by keyword Browse by category Article Bioprocessing Gene Therapy Lab of the Future News Our People Uncategorised Tags AI Automation Bioprocessing Conference Customer Success Data Demo Design of Experiments (DOE) DNA Assembly ELISA Engineeri…
Synthace Frequently Asked Questions
When was Synthace founded?
Synthace was founded in 2011.
Who are Synthace key executives?
Synthace's key executives are Christopher Grant Ward, Fane Mensah and Markus Gershater.
How many employees does Synthace have?
Synthace has 75 employees.
What is Synthace revenue?
Latest Synthace annual revenue is £581.
What is Synthace revenue per employee?
Latest Synthace revenue per employee is £8.
Who are Synthace competitors?
Competitors of Synthace include International Stem Cell Corporation, The Biomedical Engineering Society and IDEXX.
Where is Synthace headquarters?
Synthace headquarters is located at 195 Wood Ln, Shepherd's Bush, London.
Where are Synthace offices?
Synthace has offices in London and Cambridge.
How many offices does Synthace have?
Synthace has 2 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies